Alterations in Familial FSGS Genes
| Main study | Novel Therapies to Treat Resistant Focal Segmental Glomerulosclerosis: Phase II Clinical Trial |
|---|---|
| Contact name | Martin Pollack |
| Contact phone | 617-525-5840 |
| Contact email | mpollak@rics.bwh.harvard.edu |
| PI name | Martin Pollack |